Riskpilot← Back to searchSign inGet full accessGyn-teamet KLK AB
ABActiveOrg 5569713968Kungsgatan 63 AMedical specialists activities · NACE 8622Est. 20141 employees
Revenue 2025
SEK 1,3M
+5% vs 2024
EBITDA margin
16.2%
+3% vs 2024
Equity ratio
69.5%
Financial strength
Net profit 2025
SEK 168K
+1% vs 2024
| Revenue | SEK 1,3M | +5% |
| EBITDA | SEK 213K | +3% |
| Net profit | SEK 168K | +1% |
| Total assets | SEK 468K | +20% |
| Equity | SEK 325K | +26% |
| Employees | 1 | — |
Legal name
Gyn-teamet KLK AB
Org number
5569713968
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
13 maj 2014
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva läkar- och vårdtjänster inom specialområdena gynekologi och obstetrik samt därmed förenlig verksamhet.
Address
Kungsgatan 63 A
Email
katarinalik@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 496 | 1 411 | 1 274 | 1 255 | 1 314 |
| Staff expenses | — | −992 | −973 | −970 | −993 |
| EBITDA | 569 | 344 | 232 | 206 | 213 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 569 | 344 | 232 | 206 | 213 |
| Net financials | −2 | −1 | 1 | 3 | 1 |
| Profit before tax | 567 | 343 | 233 | 208 | 214 |
| Tax | −122 | −71 | −48 | −42 | −46 |
| Net profit | 445 | 272 | 185 | 166 | 168 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 761 | 539 | 391 | 390 | 468 |
| Equity | 544 | 371 | 276 | 257 | 325 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 217 | 168 | 115 | 133 | 143 |
| Total debt | 217 | 168 | 115 | 133 | 143 |
EBITDA margin
16.2%
This company
15.8%
Market median
+3% vs market
20212025
Equity ratio
69.5%
This company
38.2%
Market median
+82% vs market
20212025
Return on equity
51.6%
This company
18.4%
Market median
+180% vs market
20212025
Net profit margin
12.8%
This company
8.1%
Market median
+58% vs market
20212025
Asset turnover
2.81×
This company
1.12×
Market median
+151% vs market
20212025
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Gyn-teamet KLK AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Brusk Oskar Kösanlioglu | Deputy Board Member | 0 companies |
| Ann Katarina Lindborg Kösanlioglu | Board of Directors | 0 companies |